BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 25302800)

  • 1. Opioid-induced mitogen-activated protein kinase signaling in rat enteric neurons following chronic morphine treatment.
    Duraffourd C; Kumala E; Anselmi L; Brecha NC; Sternini C
    PLoS One; 2014; 9(10):e110230. PubMed ID: 25302800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine induces μ opioid receptor endocytosis in guinea pig enteric neurons following prolonged receptor activation.
    Patierno S; Anselmi L; Jaramillo I; Scott D; Garcia R; Sternini C
    Gastroenterology; 2011 Feb; 140(2):618-26. PubMed ID: 21070774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-induced μ opioid receptor internalization in enteric neurons following chronic treatment with the opiate fentanyl.
    Anselmi L; Jaramillo I; Palacios M; Huynh J; Sternini C
    J Neurosci Res; 2013 Jun; 91(6):854-60. PubMed ID: 23553842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mu and kappa opioid receptors activate ERK/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes.
    Belcheva MM; Clark AL; Haas PD; Serna JS; Hahn JW; Kiss A; Coscia CJ
    J Biol Chem; 2005 Jul; 280(30):27662-9. PubMed ID: 15944153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Garzón J
    Mol Pain; 2007 Jul; 3():19. PubMed ID: 17634133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
    Liu JG; Prather PL
    Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct differences between morphine- and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin-mu-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation.
    Chakrabarti S; Law PY; Loh HH
    J Neurochem; 1998 Jul; 71(1):231-9. PubMed ID: 9648870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
    Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p38 MAPK and beta-arrestin 2 mediate functional interactions between endogenous micro-opioid and alpha2A-adrenergic receptors in neurons.
    Tan M; Walwyn WM; Evans CJ; Xie CW
    J Biol Chem; 2009 Mar; 284(10):6270-81. PubMed ID: 19126537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mu-opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine.
    Bailey CP; Couch D; Johnson E; Griffiths K; Kelly E; Henderson G
    J Neurosci; 2003 Nov; 23(33):10515-20. PubMed ID: 14627635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mu opioid receptor-effector coupling and trafficking in dorsal root ganglia neurons.
    Walwyn WM; Wei W; Xie CW; Chiu K; Kieffer BL; Evans CJ; Maidment NT
    Neuroscience; 2006 Oct; 142(2):493-503. PubMed ID: 16887280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mu and delta-opioid receptor agonists induce mitogen-activated protein kinase (MAPK) activation in the absence of receptor internalization.
    Kramer HK; Simon EJ
    Neuropharmacology; 2000 Jul; 39(10):1707-19. PubMed ID: 10884553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of EGF-induced ERK/MAP kinase-mediated astrocyte proliferation by mu opioids: integration of G protein and beta-arrestin 2-dependent pathways.
    Miyatake M; Rubinstein TJ; McLennan GP; Belcheva MM; Coscia CJ
    J Neurochem; 2009 Jul; 110(2):662-74. PubMed ID: 19457093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac μ-opioid receptor contributes to opioid-induced cardioprotection in chronic heart failure.
    He SF; Jin SY; Yang W; Pan YL; Huang J; Zhang SJ; Zhang L; Zhang Y
    Br J Anaesth; 2018 Jul; 121(1):26-37. PubMed ID: 29935580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-dependent spatiotemporal signaling profiles of the μ-opioid receptor are controlled by distinct protein-interaction networks.
    Civciristov S; Huang C; Liu B; Marquez EA; Gondin AB; Schittenhelm RB; Ellisdon AM; Canals M; Halls ML
    J Biol Chem; 2019 Nov; 294(44):16198-16213. PubMed ID: 31515267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-induced mu opioid receptor endocytosis and recycling in enteric neurons.
    Minnis JG; Patierno S; Kohlmeier SE; Brecha NC; Tonini M; Sternini C
    Neuroscience; 2003; 119(1):33-42. PubMed ID: 12763066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of agonist-dependent receptor internalization in the regulation of mu opioid receptors.
    Sternini C; Brecha NC; Minnis J; D'Agostino G; Balestra B; Fiori E; Tonini M
    Neuroscience; 2000; 98(2):233-41. PubMed ID: 10854754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurokinin 1 receptors regulate morphine-induced endocytosis and desensitization of mu-opioid receptors in CNS neurons.
    Yu YJ; Arttamangkul S; Evans CJ; Williams JT; von Zastrow M
    J Neurosci; 2009 Jan; 29(1):222-33. PubMed ID: 19129399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine-induced trafficking of a mu-opioid receptor interacting protein in rat locus coeruleus neurons.
    Jaremko KM; Thompson NL; Reyes BA; Jin J; Ebersole B; Jenney CB; Grigson PS; Levenson R; Berrettini WH; Van Bockstaele EJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():53-65. PubMed ID: 24333843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase A maintains cellular tolerance to mu opioid receptor agonists in hypothalamic neurosecretory cells with chronic morphine treatment: convergence on a common pathway with estrogen in modulating mu opioid receptor/effector coupling.
    Wagner EJ; Rønnekleiv OK; Kelly MJ
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1266-73. PubMed ID: 9618432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.